TY - JOUR
T1 - Comorbid neurotrauma increases neurodegenerative-relevant cognitive, motor, and autonomic dysfunction in patients with rapid eye movement sleep behavior disorder
T2 - a substudy of the North American Prodromal Synucleinopathy Consortium
AU - the North American Prodromal Synucleinopathy (NAPS) Consortium
AU - Elliott, Jonathan E.
AU - Ligman, Brittany R.
AU - Bryant-Ekstrand, Mohini D.
AU - Keil, Allison T.
AU - Powers, Katherine
AU - Olivo, Cosette
AU - Neilson, Lee E.
AU - Postuma, Ronald B.
AU - Pelletier, Amélie
AU - Gagnon, Jean François
AU - Gan-Or, Ziv
AU - Yu, Eric
AU - Liu, Lang
AU - St. Louis, Erik K.
AU - Forsberg, Leah K.
AU - Fields, Julie A.
AU - Ross, Owen A.
AU - Huddleston, Daniel E.
AU - Bliwise, Donald L.
AU - Avidan, Alon Y.
AU - Howell, Michael J.
AU - Schenck, Carlos H.
AU - McLeland, Jennifer
AU - Criswell, Susan R.
AU - Videnovic, Aleksandar
AU - During, Emmanuel H.
AU - Miglis, Mitchell G.
AU - Shprecher, David R.
AU - Lee-Iannotti, Joyce K.
AU - Boeve, Bradley F.
AU - Ju, Yo El S.
AU - Lim, Miranda M.
AU - Ju, Yo El S.
AU - Boeve, Bradley F.
AU - Postuma, Ronald B.
AU - Avidan, Alon Y.
AU - Bliwise, Donald L.
AU - Criswell, Susan R.
AU - Duff, Kevin M.
AU - During, Emmanuel H.
AU - Elliott, Jonathan E.
AU - Fields, Julie A.
AU - Forsberg, Leah K.
AU - Gagnon, Jean François
AU - Gan-Or, Ziv
AU - Chung, Jae Woo
AU - De Kam, Joshua
AU - MacKinnon, Colum
AU - Summers, Rebekah
AU - Schenck, Carlos H
N1 - Publisher Copyright:
© 2024 Published by Oxford University Press on behalf of Sleep Research Society (SRS).
PY - 2024/6/1
Y1 - 2024/6/1
N2 - Study Objectives: Rapid eye movement sleep behavior disorder (RBD) is strongly associated with phenoconversion to an overt synucleinopathy, e.g. Parkinson's disease (PD), Lewy body dementia, and related disorders. Comorbid traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) - henceforth "neurotrauma"(NT) - increase the odds of RBD by ~2.5-fold and are associated with an increased rate of service-connected PD in Veterans. Thus, RBD and NT are both independently associated with PD; however, it is unclear how NT influences neurological function in patients with RBD. Methods: Participants ≥18 years with overnight polysomnogram-confirmed RBD were enrolled between 8/2018 to 4/2021 through the North American Prodromal Synucleinopathy Consortium. Standardized assessments for RBD, TBI, and PTSD history, as well as cognitive, motor, sensory, and autonomic function, were completed. This cross-sectional analysis compared cases (n = 24; RBD + NT) to controls (n = 96; RBD), matched for age (~60 years), sex (15% female), and years of education (~15 years). Results: RBD + NT reported earlier RBD symptom onset (37.5 ± 11.9 vs. 52.2 ± 15.1 years of age) and a more severe RBD phenotype. Similarly, RBD + NT reported more severe anxiety and depression, greater frequency of hypertension, and significantly worse cognitive, motor, and autonomic function compared to RBD. No differences in olfaction or color vision were observed. Conclusions: This cross-sectional, matched case:control study shows individuals with RBD + NT have significantly worse neurological measures related to common features of an overt synucleinopathy. Confirmatory longitudinal studies are ongoing; however, these results suggest RBD + NT may be associated with more advanced neurological symptoms related to an evolving neurodegenerative process.
AB - Study Objectives: Rapid eye movement sleep behavior disorder (RBD) is strongly associated with phenoconversion to an overt synucleinopathy, e.g. Parkinson's disease (PD), Lewy body dementia, and related disorders. Comorbid traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) - henceforth "neurotrauma"(NT) - increase the odds of RBD by ~2.5-fold and are associated with an increased rate of service-connected PD in Veterans. Thus, RBD and NT are both independently associated with PD; however, it is unclear how NT influences neurological function in patients with RBD. Methods: Participants ≥18 years with overnight polysomnogram-confirmed RBD were enrolled between 8/2018 to 4/2021 through the North American Prodromal Synucleinopathy Consortium. Standardized assessments for RBD, TBI, and PTSD history, as well as cognitive, motor, sensory, and autonomic function, were completed. This cross-sectional analysis compared cases (n = 24; RBD + NT) to controls (n = 96; RBD), matched for age (~60 years), sex (15% female), and years of education (~15 years). Results: RBD + NT reported earlier RBD symptom onset (37.5 ± 11.9 vs. 52.2 ± 15.1 years of age) and a more severe RBD phenotype. Similarly, RBD + NT reported more severe anxiety and depression, greater frequency of hypertension, and significantly worse cognitive, motor, and autonomic function compared to RBD. No differences in olfaction or color vision were observed. Conclusions: This cross-sectional, matched case:control study shows individuals with RBD + NT have significantly worse neurological measures related to common features of an overt synucleinopathy. Confirmatory longitudinal studies are ongoing; however, these results suggest RBD + NT may be associated with more advanced neurological symptoms related to an evolving neurodegenerative process.
KW - Parkinson's disease
KW - RBD
KW - REM sleep without atonia
KW - posttraumatic stress disorder
KW - synucleinopathy
KW - trauma-associated sleep disorder
KW - traumatic brain injury
UR - http://www.scopus.com/inward/record.url?scp=85191010850&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85191010850&partnerID=8YFLogxK
U2 - 10.1093/sleep/zsae007
DO - 10.1093/sleep/zsae007
M3 - Article
C2 - 38181205
AN - SCOPUS:85191010850
SN - 0161-8105
VL - 47
JO - Sleep
JF - Sleep
IS - 6
M1 - zsae007
ER -